ALEXANDRIA, Va., June 9 -- United States Patent no. 12,285,451, issued on April 29, was assigned to uniQure IP B.V. (Amsterdam).
"Means and methods for AAV gene therapy in humans" was invented by Bart Antonius Nijmeijer (Amsterdam) and Valerie Ferreira (Amsterdam).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to means and method for AAV based gene therapies in humans. In particular, the present invention relates to the treatment of human patients that may be suspected to have antibodies directed against the AAV intended for use in the treatment."
The patent was filed on June 30, 2022, under Application No. 17/854,371.
*For further information, including images, charts and tabl...